Premium
Annovis Bio Inc (ANVS)
NYSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.7892 | -28.802919708 | 2.74 | 2.77 | 1.945 | 546311 | 2.2939843 | CS |
| 4 | -2.9892 | -60.5101214575 | 4.94 | 5.03 | 1.945 | 694988 | 3.01009894 | CS |
| 12 | -4.8592 | -71.3538913363 | 6.81 | 7.39 | 1.945 | 514063 | 4.17614726 | CS |
| 26 | -7.6192 | -79.6154649948 | 9.57 | 10.54 | 1.945 | 353295 | 5.65381283 | CS |
| 52 | -7.9892 | -80.3742454728 | 9.94 | 20 | 1.945 | 755009 | 9.30549259 | CS |
| 156 | -11.3092 | -85.2880844646 | 13.26 | 23.9099 | 1.945 | 312399 | 10.02383628 | CS |
| 260 | -3.5592 | -64.5952813067 | 5.51 | 132 | 1.945 | 358342 | 24.37736864 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
